Allergan Acquires Anterios – Topical Botox May Be Around The Corner!

Allergan, a leading global pharmaceutical company, recently announced that it has acquired Anterios, Inc., a clinical stage biopharmaceutical company developing a next generation delivery system and botulinum toxin-based prescription products.  Anterios has developed a proprietary platform delivery technology (NDS) that enables local, targeted delivery of neurotoxins through the skin without the need for injections, topical botox.

What does this mean for you? Botox is currently only available as an injectable. It  is a prescription medicine that is injected into muscles and used to temporarily improve the look of both moderate to severe crow’s feet lines and frown lines between the eyebrows in adults. It is also being used to treat excessive sweating and is helpful for patients who suffer from migraines. Allergan was the company that pioneered the development and commercialization of BOTOX®, the market-leading neurotoxin used in both medical aesthetics and therapeutic areas of medicine. This acquisition will showcase their ability to apply tremendous scientific leadership in neurotoxins by advancing a new delivery system and formulations that are appealing to both patients and physicians.

Ethos Spa is dedicated to learning and using the latest technologies with our patients to enhance the treatments we perform. We promise to keep you updated on the latest news and cannot wait until a topical Botox product is ready for use. Contact us here to learn more about our treatments for Botox, laser hair removal, dermal fillers, laser tattoo removal and more.